← Browse by Condition

Medical Condition

overweight

Total Trials

18

Recruiting Now

18

Trial Phases

Phase 1, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for overweight sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — overweight Clinical Trials

How many clinical trials are currently recruiting for overweight?

ClinicalMetric currently tracks 18 actively recruiting clinical trials for overweight, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 18. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for overweight?

overweight research spans Phase 1 (1 trial), Phase 2 (1 trial), Phase 3 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a overweight clinical trial?

Eligibility criteria for overweight trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

1

Phase 2

1

Phase 3

3

Top Sponsors

Novo Nordisk A/S 4 trials

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2 trials

Duke University 2 trials

Johns Hopkins University 1 trial

Eli Lilly and Company 1 trial

Recruiting Clinical Trials

Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate

National Institute of Diabetes...

NCT07525791 Phase 1

A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight

Novo Nordisk A/S

Night Owl Metabolism

Johns Hopkins University

Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change

National Institute of Diabetes...

Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study

Duke University

NCT07589608 Phase 2

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Eli Lilly and Company

Dietary Supplementation on Fat Oxidation

NCT07571005 Phase 3

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

United States, Austr...

Novo Nordisk A/S

The FaibaGo Study - Long-Term Weight Reduction Via Low-Threshold Intervention

University of Bern

NCT07253285 Phase 3

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

United States, Austr...

Novo Nordisk A/S

The Influence of Honey-flavored Yogurt on Low-grade Inflammation and Gut Health in Middle to Older Aged Women.

University of California, Davi...

Effects of SlimTrack® Platform on Diet Adherence, Anthropometry and Arterial Stiffness in Postmenopausal Women

Instituto de Cardiologia do Ri...

The Effect of Obesity and Weight Loss in Heart Failure With Reduced Ejection Fraction.

Jersey, United Kingd...

University of Oxford

NCT07595549 Phase 3

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Improving Glycemic Control With Electrical Stimulation

University of Texas, El Paso

Effect of Partial Dietary Replacement From Animal to Plant-Based Protein for Type 2 Diabetes Management

Hospital de Clinicas de Porto ...

Weight Loss in Adults Using Semaglutide (Real-world Study)

United States, Unite...

Novo Nordisk A/S

Community Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study

Duke University

Related Conditions

obesity (15) hypertension (2) low physical fitness (2) prediabetes (1) impaired glucose tolerance (1) prehypertension (1) anxiety (1) well being (1) depression (1) psychological (1) obstructive sleep apnoea (1) nutritional and metabolic diseases (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology